Challenges for the Treatment of Diabetes Mellitus | Bentham Science
Generic placeholder image

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Editor-in-Chief

ISSN (Print): 1872-2148
ISSN (Online): 2212-3334

Challenges for the Treatment of Diabetes Mellitus

Author(s): Athanasia K. Papazafiropoulou, Marina S. Kardara and Stavros I. Pappas

Volume 5, Issue 3, 2011

Page: [203 - 209] Pages: 7

DOI: 10.2174/187221411797265953

Price: $65

Open Access Journals Promotions 2
Abstract

The present review summarizes the existing literature data regarding the development of newer categories of antidiabetic agents, their mechanism of action and their clinical importance. In this paper, a review of the recent patents for the treatment of diabetes will be presented. In recent years significant achievements have been done, including the development of SGLT2 inhibitors, glucokinase activators as well as the role of free fatty acids and bile acid metabolism in the treatment of diabetes are reviewed.

Keywords: Bile acid synthesis, Low density lipoprotein cholesterol, sodium-coupled glucose transporters, free fatty acids, glucokinase activators, SGLT2 inhibitors, Dapagliflozin, Type 2 diabetes mellitus, Diet-induced obesity


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy